Literature DB >> 30279517

Succinate receptor mediates intestinal inflammation and fibrosis.

Dulce C Macias-Ceja1, Dolores Ortiz-Masiá2, Sara Calatayud3, María D Barrachina3, Pedro Salvador3, Laura Gisbert-Ferrándiz3, Carlos Hernández1, Martin Hausmann4, Gerhard Rogler4, Juan V Esplugues1,3, Joaquín Hinojosa5, Rafael Alós6, Francisco Navarro5, Jesus Cosin-Roger7.   

Abstract

Succinate, an intermediate of the tricarboxylic acid cycle, is accumulated in inflamed areas and its signaling through succinate receptor (SUCNR1) regulates immune function. We analyze SUCNR1 expression in the intestine of Crohn's disease patients and its role in murine intestinal inflammation and fibrosis. We show that both serum and intestinal succinate levels and SUCNR1 expression in intestinal surgical resections were higher in CD patients than in controls. SUCNR1 co-localized with CD86, CD206, and α-SMA+ cells in human intestine and we found a positive and significant correlation between SUCNR1 and α-SMA expression. In human isolated fibroblasts from CD patients SUCNR1 expression was higher than in those from controls and treatment with succinate increased SUCNR1 expression, fibrotic markers and inflammatory cytokines through SUCNR1. This receptor modulated the expression of pro-inflammatory cytokines in resting murine macrophages, macrophage polarization and fibroblast activation and Sucnr1-/- mice were protected against both acute TNBS-colitis and intestinal fibrosis induced by the heterotopic transplant of colonic tissue. We demonstrate increased succinate levels in serum and SUCNR1 expression in intestinal tissue of CD patients and show a role for SUCNR1 in murine intestinal inflammation and fibrosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30279517     DOI: 10.1038/s41385-018-0087-3

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  36 in total

Review 1.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.

Authors:  Aonghus Lavelle; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-19       Impact factor: 46.802

Review 2.  Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.

Authors:  Ziying Zhang; Haosheng Tang; Peng Chen; Hui Xie; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

3.  UEG Week 2020 Poster Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

4.  Genomic adaptations of Campylobacter jejuni to long-term human colonization.

Authors:  Samuel J Bloomfield; Anne C Midwinter; Patrick J Biggs; Nigel P French; Jonathan C Marshall; David T S Hayman; Philip E Carter; Alison E Mather; Ahmed Fayaz; Craig Thornley; David J Kelly; Jackie Benschop
Journal:  Gut Pathog       Date:  2021-12-10       Impact factor: 4.181

5.  Dietary succinate supplementation to maternal mice improves fetal brown adipose tissue development and thermogenesis of female offspring.

Authors:  Xiangdong Liu; Yanting Chen; Liang Zhao; Qiyu Tian; Jeanene Marie deAvila; Mei-Jun Zhu; Min Du
Journal:  J Nutr Biochem       Date:  2021-11-18       Impact factor: 6.048

Review 6.  Critical roles of G protein-coupled receptors in regulating intestinal homeostasis and inflammatory bowel disease.

Authors:  Zhongsheng Feng; Ruicong Sun; Yingzi Cong; Zhanju Liu
Journal:  Mucosal Immunol       Date:  2022-06-22       Impact factor: 8.701

Review 7.  Revisiting fibrosis in inflammatory bowel disease: the gut thickens.

Authors:  Silvia D'Alessio; Federica Ungaro; Daniele Noviello; Sara Lovisa; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-12-07       Impact factor: 46.802

8.  Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development.

Authors:  Dolores Ortiz-Masiá; Laura Gisbert-Ferrándiz; Cristina Bauset; Sandra Coll; Céline Mamie; Michael Scharl; Juan V Esplugues; Rafael Alós; Francisco Navarro; Jesús Cosín-Roger; María D Barrachina; Sara Calatayud
Journal:  Cells       Date:  2020-04-29       Impact factor: 6.600

Review 9.  What We Know So Far about the Metabolite-Mediated Microbiota-Intestinal Immunity Dialogue and How to Hear the Sound of This Crosstalk.

Authors:  Clément Caffaratti; Caroline Plazy; Geoffroy Mery; Abdoul-Razak Tidjani; Federica Fiorini; Sarah Thiroux; Bertrand Toussaint; Dalil Hannani; Audrey Le Gouellec
Journal:  Metabolites       Date:  2021-06-21

10.  Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease.

Authors:  Jonathan Wei Jie Lee; Damian Plichta; Larson Hogstrom; Nynke Z Borren; Helena Lau; Sara M Gregory; William Tan; Hamed Khalili; Clary Clish; Hera Vlamakis; Ramnik J Xavier; Ashwin N Ananthakrishnan
Journal:  Cell Host Microbe       Date:  2021-07-22       Impact factor: 31.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.